Osthole inhibits triple negative breast cancer cells by suppressing STAT3

BACKGROUND: Triple-negative breast cancer (TNBC) is an aggressive subgroup of human breast cancer. Patients with TNBC have poor clinical outcome as they are non-responsive to current targeted therapies. There is an urgent need to identify new therapeutic targets and develop more effective treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Xuanxuan, Yin, Changtian, Zhang, Yi, Guo, Guilong, Zhao, Chengguang, Wang, Ouchen, Xiang, Youqun, Zhang, Xiaohua, Liang, Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303899/
https://www.ncbi.nlm.nih.gov/pubmed/30577812
http://dx.doi.org/10.1186/s13046-018-0992-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303899/
https://www.ncbi.nlm.nih.gov/pubmed/30577812
http://dx.doi.org/10.1186/s13046-018-0992-z

Ejemplares similares